0.7600CADMkt Cap: 14.15M CADP/E: —Last update: 2026-05-21
Crescita Therapeutics Inc., a dermatology company, provides non-prescription skincare products and prescription drug products in Canada, the United States, and internationally. It operates through three segments: Commerc…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 168.3
54.96BEURP/E 21.7
52.53BTRYP/E 27.3
33.63BPLNP/E 21.9
13.36BSEKP/E 40.3
13.24BEURP/E 30.2
12.58BTRY—
3.96BUSDP/E 33.6
loading…
Indicators:|
Key Statistics
Company
Market Cap14.15M CAD
Enterprise Value7.94M CAD
Revenue (TTM)23.22M CAD
Gross Profit11.11M CAD
Net Income (TTM)-92.00K CAD
Revenue/Share1.238 CAD
Last Price0.7600 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees65
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-122.12
EV/Revenue0.34
P/S0.61
P/B0.98
EPS (TTM)-0.01
EPS (Forward)—
52W Range
0.76000% of range0.7700
52W High0.7700 CAD
52W Low0.7600 CAD
Profitability
Gross Margin52.60%
Oper. Margin-21.38%
EBITDA Margin-0.28%
Profit Margin-0.44%
ROE-0.59%
ROA-0.45%
Growth
Revenue Growth59.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF1.07M CAD
CapEx (TTM)333.00K CAD
FCF Margin-4.23%
FCF Yield-6.94%
Net Debt-6.21M CAD
Net Debt/EBITDA95.52
Balance Sheet
Debt/Equity0.02
Current Ratio2.81
Quick Ratio2.00
Book Value/Sh0.7750 CAD
Cash/Share0.4680 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.61M
Float16.11M
Insiders24.09%
Institutions0.88%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short463
Short (prev mo.)463
Technical
SMA 500.7327 (+3.7%)
SMA 2000.5350 (+42.1%)
Beta-0.14
S&P 52W Chg28.31%
Avg Vol (30d)1.78K
Avg Vol (10d)13.55K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—